(Fighting new crown pneumonia) "China Optics Valley" key enterprises all return to bio products to go global
China News Service, Wuhan, March 26 (Reporter Xu Jinbo) The reporter learned from the Management Committee of Wuhan East Lake High-tech Zone (also known as "Wuhan · China Optics Valley") on the 26th that key enterprises in the zone and their supporting enterprises in the industrial chain are currently Resumption of production and resumption of production, Huada Biological, Mingde Biological and other companies produce products to fight the new crown pneumonia epidemic, to more than 70 countries and regions worldwide.
The Wuhan Donghu High-tech Zone, which was established in 1988, has successively been approved by the National Optoelectronic Information Industry Base, the National Biological Industry Base, and the National Memory Base. At present, the development leap from "a beam of light" to "an innovation city" has been achieved. Its comprehensive strength ranks fourth among the 168 national high-tech zones, and it is one of China's 10 key "world-class high-tech parks". Optoelectronic information and biomedicine are two leading industries.
According to the relevant person in charge of the Management Committee of Wuhan Donghu High-tech Zone, China Xinke, Yangtze River Storage, Huawei Wuhan Base, Huaxing Optoelectronics, Tianma Microelectronics, Fiberhome Communications, YOFC, BGI, Wuhan Lianying, etc. Enterprises and their 45 industrial chain supporting companies have all resumed production, and more than 200 Internet companies have resumed work.
At the same time, the Donghu High-tech Zone actively explores the “negative list management + joint prevention and control of buildings” mechanism for small and medium-sized enterprises, and encourages employees to roll back to work and work online in batches to solve the problems of prevention and control such as co-building and staff gathering. It is expected that at the end of this month, the industrial enterprises above the designated size in the zone can resume 100% of their work.
During the fight against the new crown pneumonia epidemic in China, "China Optics Valley" biomedical companies actively fulfilled their responsibilities. Huada Biological, Huada Intelligent Manufacturing, Mingde Biological, Zhongyi Biological, Kanglu Biological and other companies developed the first diagnosis of pneumonia. Gene sequencing, nucleic acid and antibody detection products; new coronavirus 2019-nCoV nucleic acid detection kits (fluorescent PCR method) from Huada Biological and Mingde Biological were registered and listed in China through the emergency approval procedure of the State Drug Administration, with a production capacity of 900,000 Servings per day; while BGI provides nucleic acid detection reagents, it has also established a "Fire Eye" laboratory with high-throughput detection capabilities.
Recently, with the gradual improvement of the epidemic situation in Wuhan, Optics Valley Biomedicine has joined the global fight against the "epidemic". BGI's new coronavirus detection kit has an international order volume of more than one million people, covering more than 70 countries and regions, and has sent expert technical teams to overseas to support the construction of "Fire Eye" laboratories. Mingde Biological's new coronavirus nucleic acid detection kit, nucleic acid extraction reagent and other 6 products have obtained EU CE approval, and have entered trials and sales in many countries. (Finish)